SD Canada Announces CE Mark for ThyroChek(R) Adult and NeoNatal Tests
Rapidly growing thyroid test market expands to EU, LATAM and
ThyroChek NeoNatal has never been available in the U.S. as testing newborns for TSH elevation; an indication of congenital hypothyroidism is performed routinely in every hospital. This is not the case in some countries of the EU. Most countries of
The market for thyroid health testing in the U.S. is
Doctors can write very few scripts without a thyroid test. TSH or thyroid stimulating hormone is, through a biofeedback mechanism, responsible for oxygen regulation in every human cell. With ThyroChek, there is no wait for a lab report as a meaningful qualitative result is available from a single drop of blood within 10 minutes. With a CLIA-waived license, the U.S. physician can keep revenue that would otherwise go to a lab, without sacrificing accuracy.
“Ordering a TSH test alone initially, followed by T4 in only those cases of abnormal TSH, will significantly decrease unnecessary testing and expense,” according to Dr.
For more information: Sharon Wyman, 647-477-5672 firstname.lastname@example.org
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.
SOURCE Screening Devices Canada, Inc.